Login

TI Ref No :	522052169
Description :	Medicines With The Active Ingredient Rivaroxaban (atc: B01af01 - In All Power Strengths Except 2.5 Mg Each Divided Oral Dosage Form)
Date :	2025-08-26
Deadline :	2026-02-22
Document Type :	Tenders